Covigilance AI cover photo
Covigilance AI

Covigilance AI

科技、信息和网络

Lightning fast medical literature review. You can save 80% literature review time with our productivity AI.

关于我们

The use of artificial intelligence (AI) in pharmacovigilance has the potential to improve the efficiency and effectiveness of drug safety monitoring greatly. We provide our users with a best-in-class interface and speed up medical literature review time for drug safety monitoring by magnitudes with the help of AI. A product of the Applied AI Company https://www.dhirubhai.net/company/aaico/

网站
https://www.aaico.com/covigilance
所属行业
科技、信息和网络
规模
51-200 人
类型
私人持股
创立
2022
领域
Pharmacovigilance

动态

  • 查看Covigilance AI的组织主页

    254 位关注者

    ?? Innovating Global Pharmacovigilance with AI Pharmacovigilance is more than just monitoring drug safety — it's about proactive, real-time action that can save lives. Here’s how AI is changing the game: Early Detection: AI analyzes vast amounts of data to spot potential safety risks long before traditional methods would. Efficiency Boost: Automated systems reduce manual labor, allowing healthcare professionals to focus on decision-making rather than data gathering. Global Compliance: With built-in local regulation awareness, AI ensures drug safety standards are met in every region. Real-World Data Integration: Harnessing clinical trials and real-world evidence gives a fuller picture of a drug's safety profile. Let’s move from reactive pharmacovigilance to a proactive, AI-driven approach. ?? Want to know more? Visit https://lnkd.in/dtqFf6cQ to explore our solutions! #Pharmacovigilance #AI #Healthcare #DrugSafety #Innovation

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    Screening medical literature for drug safety is challenging and time-consuming. However, our literature monitoring tool is at the forefront, powered by 10 systems aimed at boosting productivity: 1?? Automated literature screening for efficiency. 2?? Customisable search filters for precision. 3?? Collaborative workspaces for team synergy. 4?? Automated data extraction for accuracy. 5?? Customisable dashboards for visualisation. 6?? Integration with existing systems seamlessly. 7?? Comprehensive reporting for informed decisions. 8?? User training and ongoing support. 9?? Continuous improvement for adaptability. ?? Enhanced efficiency in pharmacovigilance operations. Want to see how this tool can transform your workflow? Book a demo now to experience it firsthand! #healthcare #pharmacovigilance #future #AItechnologies #drugmonitoring #AI #drugdevelopment #PV

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    ???? Navigating the Tightrope of Regulatory Scrutiny in Global Pharmacovigilance As the global regulatory landscape increasingly tightens, the pharmacovigilance sector is pushed to evolve rapidly.? Let's explore how increased scrutiny is affecting the industry's future. ? New PV capabilities are needed to meet the demands of evolving regulations worldwide. Hence, advanced data reporting and monitoring systems are essential, ensuring timely and accurate safety data submission. ? Less mature regulatory environments face unique challenges for compliance and safety monitoring. These regions necessitate tailored strategies to navigate inconsistent laws and standards while upholding global safety practices. ? PV teams must be agile and well-versed in global regulations to maintain balance and ensure safety. Therefore, continuous education is essential to stay ahead of regulatory changes and mitigate risks effectively. How is your organization adapting to these regulatory changes? Comment your experiences. #regulatorycompliance #globalpv #pharmaindustry #innovation

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    Great to see more top talent pushing the boundaries of Pharmacovigilance! Congratulations on your appointment, Dr Ranjit Chavan, of Clinexel Life Sciences Pvt Ltd !

    查看Dr. Deepa Arora MD的档案

    CEO- CLINEXEL

    We are delighted to announce that Dr Ranjit Chavan has joined #CLINEXEL as Head of Pharmacovigilance. Ranjit is a physician with 16 years of experience in CROs and Pharma companies. His joining further strengthens #CLINEXEL’s team of physicians and medical expertise. Ranjit is a valuable addition to #CLINEXEL’s Leadership team that includes professionally qualified Subject Matter Experts with extensive hands on experience in pharma. Average experience of the Leadership team at #CLINEXEL is 18+ years. The expertise of Leadership team of #CLINEXEL spans across NCEs, biosimilars, complex generics with strong understanding of the regulatory approval pathways- 505(b)(1), 505(b)(2) and 505(j) Ranjit has experience with Lupin, Macleods, Parexel, Cognizant and TCS. Through his experience with global CROs like Parexel, Cognizant and TCS, he got the opportunity to work with the Top Pharma MNCs and understand their safety monitoring operations during clinical development as well as after commercialization. His experience with MNC Pharma company Lupin gave him the exposure to understand the complete life cycle management of a drug.?During early phase of his career, he also got the opportunity to work as an investigator in Phase 1 unit and worked on BA/ BE studies. ? We are confident that Ranjit is a valuable addition to the #CLINEXEL team and will contribute significantly to the company's growth. Please join us in welcoming him aboard! Clinexel Life Sciences Pvt Ltd #clinexelcro

    • 该图片无替代文字
  • Covigilance AI转发了

    查看Dolcinea Chirazi的档案

    Director of Business Development -The Applied AI Company

    ?? Digital health is reshaping healthcare, yet physician resistance remains a significant barrier. Common concerns include patient privacy, resource constraints, and a preference for established practices. Bridging these gaps is vital for improving patient care and operational efficiency.? My top recommendations include: ? Training programs to provide the necessary skills and insights ? Enabling resources for seamless technology adoption ? Evidence of the positive impact on patient outcomes ? An organisational culture of innovation that champions early adopters? ? Continuous feedback and improvement to meet evolving needs Have you experienced resistance to digital health? Share your stories and solutions in the comments below! #healthcare #digitalhealth #physicianresistance #physicianeducation #healthcareinnovation

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    Navigating Pharmacovigilance Frontiers: A Global Perspective on Regional Challenges Pharmacovigilance faces diverse regional challenges. Varying regulatory frameworks pose obstacles to uniform reporting standards. ?? Logistical challenges include limited infrastructure, healthcare access, professional training, and information dissemination. ?? Regions with nascent pharmaceutical sectors and with lax legislative frameworks can struggle with safety requirements. Recognizing and addressing these regional intricacies is vital for building a globally effective pharmacovigilance network. This is why regular cross border exchanges, like the recent GCC Regulatory Affairs Pharma Summit, offers a forum for discussion amongst like-minded industry professionals that want to push forward the discussion on overcoming these regional obstacles. Were you at the GCC Regulatory Affairs Pharma Summit and attended Dolcinea Chirazi's discussion about Regulatory Digitization - Influence of AI? What do you think about how AI can help bridge these regional challenges? #pharma #healthcare #pharmacovigilance #healthcareindustry

    • 该图片无替代文字
  • Covigilance AI转发了

    查看Dolcinea Chirazi的档案

    Director of Business Development -The Applied AI Company

    ???? Ambient Intelligence: Exciting Developments in Healthcare ???? Imagine a healthcare environment that uses contactless sensors and wearable devices to react to people's needs and create a more comfortable, personalised experience for both patients and healthcare workers alike. That's exactly what ambient intelligence sets out to do. Let's explore how this innovative concept is reshaping healthcare for the better! ?? ?? Understanding Ambient Intelligence Traditional forms of healthcare technology, such as medical devices or electronic health records, can be intrusive and less responsive to patient needs. With ambient intelligence, the technology adapts to the needs and behaviours of patients, providing tailor-made, personalised care. ??Impact on Patient Care Ambient intelligence is all about patient comfort, personalised care, and safety. Room settings that can be adjusted to personal preferences, care adapted based on individual needs, and remote monitoring capabilities that can track vitals and alert staff all play a role in creating an individualised, beneficial experience for patients. Real-time data analysis can also increase diagnosis accuracy and improve treatment planning. ?? The Future of AI and Emotion Recognition How much potential do AI and emotion recognition hold in transforming the healthcare industry? Such technologies could be used to detect changes in patient mood and adjust care accordingly. They could also be beneficial for non-verbal patients or those with reduced speech capabilities. In any case, ethical concerns will be at the forefront, and regulation is essential to protect data privacy and avoid potential misuse. How do you see this transformative technology shaping the future of healthcare? Share your thoughts and predictions in the comments. ?? #healthcare #ambientintelligence #future #AI

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    Cutting Costs, Not Corners: Economic Pressures on PV Economic efficiency is more than a buzzword in today's PV climate. Explore how organisations are finding cost-effective measures that uphold patient safety. 1?? The new era of automation presents ample opportunities for cost-saving while upholding high standards. 2?? Using data science can help streamline processes, minimize errors & provide rich insights into adverse events. While cost-reduction is essential, it's equally critical to consider the ethical implications in patient care. Have ideas on balancing cost and care in pharmacovigilance? Contribute to the conversation with your strategies. #CostEfficiency #Pharmacovigilance #PatientSafety #healthcare

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    Dolcinea Chirazi from The Applied AI Company (AppliedAI) had the pleasure of moderating an engaging discussion on the Influence of AI on Regulatory Digitization at the GCC Regulatory Affairs Pharma Summit. An extremely interesting and relevant topic, especially with the advancements the UAE is making in this sector!

    查看GCC Regulatory Affairs Pharma Summit的组织主页

    19,036 位关注者

    SESSION HIGHLIGHT! Regulatory Digitization - Influence of Ai, moderated by Ms. Dolcinea Chirazi ?from The Applied AI Company (AppliedAI)?, with Mr. Fabrizio Maniglio from Honeywell, Eng. Nusaibah Al-Jaloudi from Pi Pharma Intelligence and our two panelists from Takeda, Mr. Benjamin Ping and Mr. Rafael Rozenblum. Stay tuned for more updates! In the meantime, check out the website for more insights and information:?www.pramagcc.com #regulatoryaffairs?#pharmacuetical?#GCCRegulatoryAffairsPharmaSummit?#UAE?#Healthcare?#PV?#GCCRegion?#GCC?#pharma?#Pharmaceutical?#PharmaceuitcalIndustry

    • 该图片无替代文字
  • 查看Covigilance AI的组织主页

    254 位关注者

    Dolcinea Chirazi's insights from the first day at the GCC Regulatory Affairs Pharma Summit, with Dr. Rahul Rajan! Be sure to catch Dolcinea Chirazi moderating slot at 12pm tomorrow!

    查看Dolcinea Chirazi的档案

    Director of Business Development -The Applied AI Company

    Day 1 Highlights from the GCC Regulatory Affairs Conference 2024 ?? Exciting first day at the GCC Regulatory Affairs Conference with a record attendance! We dived deep into the crucial role of precise problem framing to transform regulatory challenges into innovation opportunities. Not only is this approach crucial for transforming challenges into opportunities but also a key driver for innovation, particularly in the regulatory domain, where precision and foresight are paramount. I am looking forward to my moderating opportunity tomorrow on Regulatory Digitization and the Influence of AI

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字

相似主页

查看职位